News About: Goverment
Falsified test results storm likely to hit pharmaceutical industry
Domestic pharmaceutical industry will take a heavy beating again as the Korea Food and Drug Administration will additionally announce a list of 370 items to be involved in the second manipulated test results on July 6...
Industry seriously worried economic evaluation of drugs.
The drug industry seriously worried the economic evaluation of drugs for the new drug pricing system called "Positive list system" judging by the fact that most of local drug companies did not fully understand the eva...
Drug economic evaluation to compare with most frequently prescribing drugs.
The comparative drug in the drug economic evaluation seems to be selected from the drugs most frequently prescribed among the same therapeutic groups.
Besides, the drug economic evaluation proposed by a local drug...
KFDA to unveil fabricated test results of 337 generic drugs in July
The Korea Food and Drug Administration (KFDA) plans to unveil the second results of its ongoing investigation into 337 generic drugs within this month.
On April 25, the KFDA announced four bioresearch centers falsi...
Ubidecarenone ranks 1st in 2005 bulk output
Daewoong Chemical's ubidecarenone ranked 1st in terms of bulk output value in 2005, according to the report by the Korea Pharmaceutical Manufacturers Association.
The output of ubidecarenone, which was locally prod...
Health ministry sets aside 69.7 billion won for health and medical sector
The Ministry of Health and Welfare said that it will spend 69.7 billion won to support the nation's health and medical sector in 2007.
The ministry proposed next year's health and welfare budget bill of 19.3 trilli...
KFDA named 4 new regional heads
The KFDA newly appointed 4 regional KFDA heads on June 29 as Mr. Kim Young-chan at Guangju, Lee Joon-geun at Seoul, Lee Gae-yoong at Gyeongin and Park Soo-cheon at Daejon.
Mr. Kim Yong-hyeon, the former Guangju KFD...
Oral anticancer drug Nexavar granted KFDA approval
Bayer Korea announced on June 28 that the Korea Food and Drug Administration (KFDA) has approved the local marketing of Nexavar (sorafenib) tablets for the first-line treatment of patients with advanced renal cell car...
504 frequently prescribing or expensive drugs require bio equivalency test.
The KFDA disclosed a draft of bill titled "Ordinance of designating drugs required for the bio equivalency tests (draft)" on June 28 covering that the bio equivalency test for the total 504 drugs including 273 drugs r...
NGO still calls for reduction of Iressa price
AstraZeneca Korea's statement that a civil group's petition on the reduction of insurance price of Iressa (gefitinib) is groundless is rekindling another refutation statement.
In its statement on June 28, the Healt...